Key Financial Data Of Reporting Company

ZERIA PHARMCEUTICAL CO., LTD. - Filing #7301461

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2023-09-30
2023-04-01 to
2023-09-30
Key financial data of reporting company
Business results of reporting company
Net sales
42,422,617,000 JPY
75,725,075,000 JPY
36,678,404,000 JPY
Ordinary profit (loss)
7,949,373,000 JPY
8,513,028,000 JPY
5,495,938,000 JPY
Net assets
88,567,842,000 JPY
79,828,792,000 JPY
75,962,478,000 JPY
Total assets
158,339,762,000 JPY
150,533,593,000 JPY
148,158,847,000 JPY
Basic earnings (loss) per share
137.51
175.39
122.43
Diluted earnings per share
Equity-to-asset ratio
0.557 xbrli:pure
0.529 xbrli:pure
0.511 xbrli:pure
Net cash provided by (used in) operating activities
8,695,150,000 JPY
12,183,609,000 JPY
4,964,771,000 JPY
Net cash provided by (used in) investing activities
-1,146,251,000 JPY
-3,952,373,000 JPY
-2,186,567,000 JPY
Net cash provided by (used in) financing activities
-5,130,935,000 JPY
-8,124,090,000 JPY
-2,285,403,000 JPY
Cash and cash equivalents
22,168,731,000 JPY
18,604,144,000 JPY
18,343,022,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.